A potential new biomarker for predicting future cognitive resilience versus decline among people with early Alzheimer's ...

BIIB080 is an antisense oligonucleotide therapy designed to target microtubule-associated protein tau mRNA and reduce the production of tau.

Enigma Biomedical USA Inc. has selected two four-repeat tau (4R tau) protein PET imaging biomarkers to advance into phase I studies. These imaging biomarkers show promise as important new tools in ...

Abnormal accumulation of tau protein in the brain has been associated ... Findings showed BIIB080 dose-dependently reduced soluble tau biomarkers in cerebrospinal fluid (t-tau and p-tau181 ...

Researchers simulated interactions between microbial molecules and neural receptors to explore whether gut bacteria might influence brain chemistry.

Researchers have developed a blood test based on a protein biomarker for tau tangles that can help diagnose Alzheimer’s ...